Assessment of CCM in HF With Higher Ejection Fraction

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1500 participants.

Also called NCT05064709

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05064709
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05064709. Randomized; quadruple masking; primary purpose treatment. Start 2022-02-03 (actual); primary completion 2029-02-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Assessment of CCM in HF With Higher Ejection Fraction
Acronym
AIM HIGHer
Condition
Heart Failure
Condition
Heart Failure With Mid Range Ejection Fraction
Condition
Heart Failure With Moderately Reduced Ejection Fraction
Condition
Diastolic Heart Failure
Intervention (Device)
Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System
Intervention (Device)
OPTIMIZER™ Smart Mini System
Lead sponsor
Impulse Dynamics (class: industry)

Record details

Record id
cardio:ct-nct05064709
Content hash
9b4d5808d02e676af1978021d1dddf62fff5f19566d86168f65b64a5801e7c71